Option Care Health (NASDAQ:OPCH) Given New $38.00 Price Target at Barrington Research

Option Care Health (NASDAQ:OPCH) had its price target lifted by Barrington Research from $33.00 to $38.00 in a report published on Thursday,Benzinga reports. Barrington Research currently has an outperform rating on the stock.

Several other research firms have also issued reports on OPCH. Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and boosted their price target for the company from $26.00 to $33.00 in a report on Monday, January 13th. Truist Financial reduced their price target on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research report on Friday, November 1st. The Goldman Sachs Group downgraded Option Care Health from a “buy” rating to a “neutral” rating and cut their target price for the company from $38.00 to $27.00 in a research report on Monday, November 4th. JPMorgan Chase & Co. upped their target price on Option Care Health from $38.00 to $40.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Finally, UBS Group began coverage on shares of Option Care Health in a research note on Thursday, December 5th. They set a “neutral” rating and a $26.00 target price for the company. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $32.88.

Option Care Health Stock Up 0.2 %

Option Care Health stock opened at $33.20 on Thursday. The firm has a market cap of $5.65 billion, a price-to-earnings ratio of 27.90, a PEG ratio of 2.30 and a beta of 1.35. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health has a 12 month low of $21.39 and a 12 month high of $34.17. The stock has a fifty day simple moving average of $28.49 and a two-hundred day simple moving average of $28.07.

Institutional Trading of Option Care Health

Hedge funds have recently made changes to their positions in the company. Murphy & Mullick Capital Management Corp acquired a new stake in shares of Option Care Health in the fourth quarter valued at $26,000. UMB Bank n.a. raised its stake in Option Care Health by 41.7% during the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock worth $27,000 after acquiring an additional 346 shares in the last quarter. Signaturefd LLC grew its position in shares of Option Care Health by 487.9% during the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock worth $28,000 after acquiring an additional 1,005 shares during the last quarter. Quadrant Capital Group LLC raised its stake in Option Care Health by 172.8% during the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company’s stock valued at $40,000 after acquiring an additional 1,099 shares during the last quarter. Finally, Public Employees Retirement System of Ohio raised its holdings in Option Care Health by 21.6% during the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company’s stock worth $43,000 after purchasing an additional 332 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.